Sign in

CIK 0001513525

  • Non-accelerated filer
  • Smaller reporting company

Azora Therapeutics, Inc. (DE)

Sign in to watch
Ticker
AZR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
800667150
Phone
+1 434-422-9800
Business address
16501 VENTURA BLVD, SUITE 400, ENCINO, CA, 91436
Former names
ADIAL PHARMACEUTICALS, INC., Adial Pharmaceuticals, L.L.C., ADial Pharmaceuticals, L.L.C.
  1. 4 Derivatives Options or other derivatives
  2. 4 Grant or award Chief Executive Officer acquired 201,109 shares (grant or award)
  3. 4 Grant or award Director acquired 3,731 shares (grant or award)
  4. 4/A Derivatives Options or other derivatives
  5. 4/A Open-market buy Director bought 90,000 shares
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market sale Chief Medical Officer sold 350,000 shares at $1.21 ($423,500)
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market buy Director bought 19,644 shares at an average $1.36 ($26,769)
  11. 4 Open-market buy Chief Executive Officer bought 25,000 shares at an average $1.30 ($32,552)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Grant or award Chief Executive Officer acquired 54,167 shares (grant or award)
  15. 4 Grant or award Chief Financial Officer acquired 27,084 shares (grant or award)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market sale Chief Medical Officer sold 150,000 shares at $1.00 ($150,000)
  20. 4 Grant or award Chief Medical Officer acquired 3,187 shares (grant or award)

Page 5 of 7 · 123 filings